Argitalpenak (520) Domingo Francisco Javier Díez Martínez argitalpenak

2024

  1. Advancing the fight against fibrosis in patients with heart failure: The contribution of sodium–glucose cotransporter 2 inhibition

    European Journal of Heart Failure

  2. Cardiovascular risk assessment: Missing albuminuria contributing to gender inequality

    Nefrologia

  3. Circulating biomarkers of myocardial remodelling: current developments and clinical applications

    Heart

  4. Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565

  5. Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management

    Hypertension, Vol. 81, Núm. 2, pp. 218-228

  6. Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact

    Matrix Biology, Vol. 134, pp. 1-22

  7. Possible Role of Gut Microbiota Alterations in Myocardial Fibrosis and Burden of Heart Failure in Hypertensive Heart Disease

    Hypertension, Vol. 81, Núm. 7, pp. 1467-1476

  8. Practical Approaches to the Management of Cardiorenal Disease beyond Congestion

    Cardiorenal medicine, Vol. 14, Núm. 1, pp. 235-250

  9. Reassessing the management of hypertension: Time to prevent aldosterone-mediated heart failure

    European Journal of Heart Failure, Vol. 26, Núm. 2, pp. 195-198

  10. Selective glomerular hypofiltration syndrome

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 1, pp. 10-17

  11. The implementation of cardionephrology in Spain is a health emergency

    Nefrologia, Vol. 44, Núm. 5, pp. 619-622

  12. Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study

    Cardiorenal medicine, Vol. 14, Núm. 1, pp. 202-214

  13. Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

    Heart